MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202524025820 A) filed by Stalicla Sa, Geneva, on March 21, for 'treatment for autism spectrum disorder.'
Inventor(s) include Durham, Lynn; and Hyvelin, Jean-Marc.
The application for the patent was published on Sept. 26, under issue no. 39/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to pharmaceutical composition comprising ibudilast and bumetanide as active ingredients for use in the treatment of autism spectrum disorder (ASD), wherein the treatment induces favorable changes in the EEG of the patient."
Disclaimer: Curated by HT Syndication.
